MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 16, 2007; DOI: 10.1124/mol.107.040170


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.040170v1
73/1/50    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Dmitry Gorbunov
Valentin Gorboulev
Natalia Shatskaya
Thomas Mueller
Ernst Bamberg
Thomas Friedrich
Hermann Koepsell
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorbunov, D.
Right arrow Articles by Koepsell, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gorbunov, D.
Right arrow Articles by Koepsell, H.


Received for publication July 19, 2007.
Revised October 16, 2007.
Accepted for publication October 16, 2007.

High-affinity Cation Binding to Transporter OCT1 Induces Movement of Helix 11 and Blocks Transport after Mutations in a Modelled Interaction Domain between Two Helices

Dmitry Gorbunov 1, Valentin Gorboulev 1, Natalia Shatskaya 1, Thomas Mueller 1, Ernst Bamberg 2, Thomas Friedrich 3, Hermann Koepsell 1*

1 University Wurzburg 2 Max-Planck-Institute of Biohysics 3 Technical University of Berlin

* Address correspondence to: E-mail: hermann{at}koepsell.de

Abstract

Voltage clamp fluorometry was performed with a cysteine-deprived mutant of rat organic cation transporter 1 (rOCT1) in which phenylalanine 483 in the 11th transmembrane {alpha}-helix (TMH) close to the extracellular surface was replaced by cysteine and labeled with tetramethylrhodamine-6-maleimide (TMRM). Potential-dependent fluorescence changes were observed that were sensitive to presence of substrates choline, tetraethylammonium (TEA) and 1-methyl-4-phenylpyridinium (MPP) and of the non-transported inhibitor tetrabutylammonium (TBuA). Using potential-dependent fluorescence changes as readout one high-affinity binding site per substrate and two high-affinity binding sites for TBuA were identified in addition to the previously described single interaction sites. In a structure model of rOCT1 with an inward open cleft that was derived from a known crystal structure of lacY permease, phenylalanine 483 is close to tryptophan 147 in the 2nd TMH. In contrast, in a model with an outward open cleft these amino acids are far apart. After replacement of phenylalanine 483 or tryptophan 147 by cysteine or serine, high-affinity binding of TBuA leads to inhibition of MPP or TEA uptake whereas it has no effect on cation uptake by wildtype rOCT1. Coexisting high-affinity cation binding sites in organic cation transporters may collect low concentration xenobiotics and drugs, however, translocation including transitions between outward and inward oriented conformations may only be induced when a low-affinity cation binding site is loaded. We propose that cations bound to high-affinity sites may be translocated together with cations bound to low affinity sites or may block the translocation mechanism.


Key words: Biogenic Amine, Ion transporters (SERCA, Na/K ATPase, CFTR), Structure-activity relationships and modeling, Fluorescence techniques, Mutagenesis/Chimeric approaches, Liver transporters, Structure/function/mechanism





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics